Significant surge in geriatric
population, in the last few years, has led to growing prevalence of SCAs. This
factor has been highly beneficial to the implantable defibrillators market. At the same time, advent of novel technologies
and rise in incorporation of S-ICDs are projected to pave the way for
widespread opportunities in the industry.
As stated by
the CDC statistics, cardiovascular syndromes are known to bring about approximately
eighteen million deaths across the globe annually. Nevertheless, the frequency
is statically expanding throughout different economies, provided the escalating
disposable incomes, deskbound lifestyle, and increasing consumption of alcohol
among individuals.
According
To Allied Market Research, the global Singapore implantable defibrillators market is projected to cite a whopping CAGR from 2021 to 2030.
ICD,
(Implantable cardioverter defibrillator) is a high-end contraption entrenched
inside the human body to carry out functions such as proper pacing,
cardioversion, and defibrillation of the heart. The device is mainly utilized
in dealing with sudden cardiac arrest due to conditions including pulseless
ventricular tachycardia, ventricular fibrillation, and cardiac arrhythmias.
And, the fact that it is a very safe procedure and is clinically tested &
proven has made it a preferred choice among the patients as well as the medical
practitioners.
The market
is being further propelled by the constant advancements in technology and innovative
product developments in the sphere. As for example, in 2020, Abbott, renowned
name in the industry, confirmed receiving an FDA approval for its next-generation
defibrillator devices. In keeping with the company executives, the devices tend
to provide Bluetooth technology and smartphone applications for new patients along
with the feature of remote monitoring.
Request for Sample Report for
More Insights @ https://www.alliedmarketresearch.com/request-sample/2091
Top Leading Players:
·
Abbott
·
Biotronik SE & Co. KG
·
Boston Scientific Corporation
·
Fukuda Denshi Co. Ltd.
·
Imricor Medical Systems
·
Koninklijke Philips N.V.
·
Livanova Plc Company
·
Medtronic Plc
·
Microport Scientific Corporation
·
Nohen Kohden Corporation
Covid-19 scenario
Here, it’s worth stating that
the outbreak of the Covid-19 pandemic gave way to a steep increase in the
number heart patients along with several cardiovascular syndromes. Since the
heart patients are more susceptible to get infested by the virus, the cases of
heart implants also came experienced a sharp leap during the pandemic,
especially during the initial period. Covid-19 can have a quick impact on the
cardiovascular structure of a human body, leading to myocardial injury, and sometimes
to abrupt cardiac death. Cardiac arrest in individuals suffering from Covid-19 had
become a serious concern among the clinicians, which in turn amplified demand
for implantable defibrillators to a significant extent. In a nutshell, the
Covid-19 pandemic has had a positive impact on the global Singapore implantable
defibrillators market.
0 Comments